International Conference on Pharmaceutical Analysis, Drug Discovery and Designing Chemistry
PADDDC
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This track will explore novel methodologies and technologies in pharmaceutical analysis, focusing on their application in drug development and quality control. Participants will discuss the impact of these advancements on regulatory compliance and patient safety.
SDG 3
SDG 9
This session will highlight cutting-edge approaches in drug discovery, including high-throughput screening and computational drug design. The discussions will emphasize the integration of interdisciplinary strategies to enhance therapeutic efficacy.
SDG 3
SDG 9
This track will address the ethical challenges faced in medical research, particularly in the context of clinical trials and patient consent. Participants will engage in discussions on balancing scientific advancement with ethical responsibilities.
SDG 3
SDG 16
This session will focus on sustainable methodologies in pharmaceutical chemistry, including green chemistry principles and waste reduction strategies. The aim is to promote environmentally friendly practices in drug manufacturing and development.
SDG 12
SDG 13
This track will explore the role of biotechnology in the development of novel therapeutics, including biologics and biosimilars. Discussions will center on the challenges and opportunities presented by biotechnological innovations in the pharmaceutical industry.
SDG 3
SDG 9
This session will delve into the implications of pharmacogenomics in tailoring drug therapies to individual genetic profiles. Participants will discuss the potential for personalized medicine to enhance treatment outcomes and minimize adverse effects.
SDG 3
SDG 10
This track will examine the evolving regulatory landscape governing pharmaceutical development, including the role of agencies in ensuring drug safety and efficacy. The discussions will highlight best practices for compliance and innovation.
SDG 3
SDG 16
This session will focus on the latest trends in medical biotechnology, including gene editing and regenerative medicine. Participants will discuss the potential applications and ethical considerations of these transformative technologies.
SDG 3
SDG 9
This track will explore strategies for integrating sustainability into healthcare systems, addressing the environmental impact of medical practices. Discussions will focus on innovative solutions for reducing the carbon footprint of healthcare.
SDG 3
SDG 12
This session will investigate the application of nanotechnology in enhancing drug delivery systems, focusing on improved bioavailability and targeted therapies. Participants will discuss the challenges and future directions of nanomedicine.
SDG 3
SDG 9
This track will highlight the importance of interdisciplinary collaboration in drug design, bringing together insights from chemistry, biology, and medicine. Participants will share case studies that exemplify successful integrative strategies in drug development.
SDG 3
SDG 9